EBF1 is a tumor-promoting TF in triple-negative breast cancer (24), whereas SNAI1/2 are master regulatory TFs for organogenesis and wound healing in normal tissue as well as for the epithelial–mesenchymal transition (EMT) in cancer cells (25). Here, EBF1 is linked to cancer.